B5-021 EBM C. difficile Flashcards

1
Q

causative agent of antibiotic associated colitis

A

C. difficile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common microbial cause of HAIs in US hospitals

A

C. difficile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how does a C. difficle superinfection occur?

A
  1. C. dif acquisition
  2. Antibiotics knock out normal GI flora
  3. C. diff superinfection and antibiotic associated colitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how many patients experience recurrence following C. diff infection?

A

1 in 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what was the null hypothesis in a non-inferiority trial?

A

is the new treatment inferior to the standard treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the biggest limitation of a systematic review?

A

lack of clarity in the primary study question

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

major differences in the outcome seen among the studies included in systematic reviews

A

heterogeneity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • frequently used to estimate treatment effects
  • can provide justification for formal RCT
A

observational cohort study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does heterogenity suggest in systematic reviews that include both RCTs and observational cohort studies?

A

confounding in observational studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what type of bias are we concerned about in a systematic review?

A

confounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PICO

A

Population
Intervention
Control
Outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why do we randomize patients?

A

to ensure both groups are relatively equal at baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NNT calculation

A

1/ARR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

study population is defined on the basis of outcome status with backwards directionality

A

case control study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

works well in situations where the outcome of interest is rare

A

case control study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

small study that aggregates information on a few studies and is typically used to describe a new or novel clinical presentation

A

case series study

17
Q

compares frequency of and exposure and outcome at a population level

A

ecologic study

18
Q

when the exposure of interest and outcome of interest are assessed at the same time, a […] design is employed

A

cross sectional

19
Q

conducted using one time survey

A

cross sectional study

20
Q

used to calculate prevalence of certain condition, exposure, or state

A

cross sectional study

21
Q

used to describe continous data

A

mean
median
mode

22
Q

best used to describe cumulative data across study populations

A

mean and standard deviation

23
Q

best used for categorical data

24
Q

allows researchers to compare two treatments and evaluate if the treatment of interest is as good as the control

A

non inferiority trial

25
bias of concern in cross sectional and case control designs
recall
26
addresses possible problems in the makeup of the study population
selection bias
27
* observer-expectancy effect * researcher unconsciously influences study participants due to some unrecognized cognitive bias
pygmallion effect
28
participants change behavior because they are being observed
Hawthorne effect
29
length of time between detection of disease and the time when usual clinical presentation will occur is altered due to study
lead time bias
30
why survival time is not used as an indicator of screening test effectiveness in RCT
lead time bias
31
time is added preferentially to the screened group just because the disease was detected prior to typical clinical presentation
lead time bias